Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenue
Product sales	$ 652,792	$ 912,548
Cost of product sales	272,736	366,409
Gross profit from product sales	380,056	546,139
Other Revenue
Retained royalties	37,007	105,850
Other income	82,069	51,315
Total other revenue	119,076	157,165
Expenses
Selling expenses	159,245	391,435
Personnel and consulting expenses	1,100,041	1,419,887
General and administrative expenses	1,760,585	1,759,777
Interest expense	209,953	82,557
Unrealized (gain) loss on derivative instrument	(58,538)	53,745
Total Expenses	3,171,286	3,707,401
Loss before income taxes	(2,672,154)	(3,004,097)
Provision (benefit) for income taxes
Net loss	$ (2,672,154)	$ (3,004,097)
Basic loss per share	$ (0.16)	$ (0.20)
Basic weighted average number of common shares outstanding	16,977,027	15,007,852
Diluted loss per share	$ (0.16)	$ (0.20)
Diluted weighted average number of common shares outstanding:	16,977,027	15,007,852